We know every patient is unique and no two conditions are identical. With this in mind, the lung treatment option provided to you will be based on your individual needs to ensure the best possible outcome.
Currently located in Tampa, Florida and Franklin, Tennessee, the Lung Institute is committed to providing patients with a more effective way to address lung diseases such as chronic obstructive pulmonary disease (COPD), emphysema and other lung disorders.
The Lung Institute utilizes autologous stem cells, which are derived from the patient’s own body for both the adipose (fat-derived) and the venous (blood-derived) stem cell procedures. During these procedures, stem cells are extracted, isolated and then immediately introduced back into the body where they divide and replicate into healthy cells specialized to the damaged tissue. The use of autologous stem cells in transplantation is considered to be more reliable than stem cells from another individual as there is a much lower probability of rejection due to the fact that autologous stem cells are derived from the patient’s own body. Both adipose and venous stem cells have shown anti-inflammatory properties beneficial to patients with lung disease.
Stem cells have the ability to self-renew indefinitely, meaning they have the capability to divide many times, and they specialize in the repair of damaged organs while still sustaining the original undifferentiated cell. Depending on the nature of the patient’s condition and their health history, the adipose procedure is always performed in conjunction with the venous procedure while the venous procedure may be performed on its own.
See what our patients are saying about their stem cell therapy for lung disease.